최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Korean journal of acupuncture, v.38 no.3, 2021년, pp.140 - 150
류광현 (경희대학교 한의과대학 해부학교실) , 김엄지 (경희대학교 한의과대학 해부학교실) , 김민선 (경희대학교 한의과대학 해부학교실) , 김재현 (경희대학교 한의과대학 해부학교실) , 이유진 (경희대학교 한의과대학 해부학교실) , 진대환 (경희대학교 한의과대학 해부학교실) , 손영주 (경희대학교 한의과대학 해부학교실) , 정혁상 (경희대학교 한의과대학 해부학교실)
Objectives : The increase of osteoclasts could cause osteoporosis and bone-related diseases. Also, the inhibition of osteoclast differentiation is important in treating bone-related diseases. Traditionally, Psoraleae Semen has been used for geriatric diseases, aging and musculoskeletal diseases. The...
Lane JM, Russell L, Khan SN. Osteoporosis. Clinical Orthopaedics and Related Research. 2000 ; (372) : 139-50. https://doi.org/10.1097/00003086-200003000-00016
Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000 ; 289(5484) : 1508-14. https://doi.org/10.1126/science.289.5484.1508
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003 ; 423(6937) : 337-42. https://doi.org/10.1038/nature01658
Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev. 2001 ; 11(5) : 527-32. https://doi.org/10.1016/s0959-437x(00)00228-8
Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002 ; 2(4) : 389-406. https://doi.org/10.1016/s1534-5807(02)00157-0
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulaton of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999 ; 20(3) : 345-57. https://doi.org/10.1210/edrv.20.3.0367
Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012 ; 23(11) : 582-90. https://doi.org/10.1016/j.tem.2012.05.005
Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim HH. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun. 2006 ; 351(1) : 99-105. https://doi.org/10.1016/j.bbrc.2006.10.011
Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab. 2014 ; 21(4) : 233-41. https://doi.org/10.11005/jbm.2014.21.4.233
Kim K, Lee SH, Kim JH, Choi Y, Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol. 2008 ; 22(1) : 176-85. https://doi.org/10.1210/me.2007-0237
Reid IR. Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies. Skeletal Radiol. 2011 ; 40(9) : 1191-6. https://doi.org/10.1007/s00256-011-1164-9
McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, et al. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med. 2013 ; 126(1) : 13-20. https://doi.org/10.1016/j.amjmed.2012.06.023
Kim JY, Song YS. East-West medical examination of osteoporosis. J Korean Med Rehabil. 1996 ; 6(1) : 293-315.
Medical College of Nanjing University of Traditional Chinese Medicine. Interpretation of the Yellow Emperor's Internal Classics. Shanghai. Shanghai Science and Technology Press. 1983 : 4-5.
Herbology Editorial Committee of Korean Medicine : Herbology. Younglimsa 2009 ; 607-8.
Oh MS, Kim DR, Kim SY, Chang MS, Park SK. Antioxidant Effects of Psoraleae Fructus in GC-1 Cells. J Physiol Pathol Korean Med. 2005 ; 19(1) : 81-6.
Jeong JC, Jang YS, Min GW. Peroxynitrite Scavenging Mechanism of Psoralea corylifolia. J Int Korean Med. 2004 ; 25(2) : 268-76.
Park YK, Kang BS. Effects of Psoraleae Semen on Antioxidation in Rat's liver. Kor J Herbol. 1996 ; 11(2) : 101-14.
Seo BI, Kim SH. A Study on the Effects of Allii Tuberosi Semen in Ovariectomized Osteoporosis of Rats. Herbal Formula Science. 1997 ; 5(1) : 179-83.
Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res. 2000 ; 15(1): 103-10. https://doi.org/10.1359/jbmr.2000.15.1.103
Charles JF, Aliprantis AO. Osteoclasts: more than 'bone eaters'. Trends Mol Med. 2014 ; 20(8) : 449-59. https://doi.org/10.1016/j.molmed.2014.06.001
Rumpler M, Wurger T, Roschger P, Zwettler E, Sturmlechner I, Altmann P, et al. Osteoclasts on Bone and Dentin In Vitro: Mechanism of Trail Formation and Comparison of Resorption Behavior. Calcif Tissue Int. 2013 ; 93(6) : 526-39. https://doi.org/10.1007/s00223-013-9786-7
Zhao Q, Wang X, Liu Y, He A, Jia R. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol. 2010 ; 42(5) : 576-9. https://doi.org/10.1016/j.biocel.2009.12.018
Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006 ; 10(6) : 771-82. https://doi.org/10.1016/j.devcel.2006.04.006
Arai A, Mizoguchi T, Harada S, Kobayashi Y, Nakamichi Y, Yasuda H, et al. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. J Cell Sci. 2012 ; 125(Pt 12) : 2910-7. https://doi.org/10.1242/jcs.099986
Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 ; 3(6) : 889-901. https://doi.org/10.1016/s1534-5807(02)00369-6
Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999 ; 13(18) : 2412-24. https://doi.org/10.1101/gad.13.18.2412
Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis. Int J Mol Sci. 2016 ; 17(6) : 868. https://doi.org/10.3390/ijms17060868
Lehenkari P, Hentunen TA, Laitala-Leinonen T, Tuukkanen J, Vaananen HK. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp Cell Res. 1998 ; 242(1) : 128-37. https://doi.org/10.1006/excr.1998.4071
Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC, et al. The role of osteoclast-associated receptor in osteoimmunology. J Immunol. 2011 ; 186(1) : 13-8. https://doi.org/10.4049/jimmunol.1002483
Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest. 2011 ; 121(9) : 3505-16. https://doi.org/10.1172/JCI45913
Kodama J, Kaito T. Osteoclast Multinucleation: Review of Current Literature. Int J Mol Sci. 2020 ; 21(16) : 5685. https://doi.org/10.3390/ijms21165685
Wu H, Xu G, Li YP. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res. 2009 ; 24(5) : 871-85. https://doi.org/10.1359/jbmr.081239
Chiu YH, Ritchlin CT. DC-STAMP: A Key Regulator in Osteoclast Differentiation. J Cell Physiol. 2016 ; 231(11) : 2402-7. https://doi.org/10.1002/jcp.25389
Courtial N, Smink JJ, Kuvardina ON, Leutz A, Gothert JR, Lausen J. Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J. 2012 ; 26(2) : 523-32. https://doi.org/10.1096/fj.11-190850
※ AI-Helper는 부적절한 답변을 할 수 있습니다.